Unity Biotechnology

Mizuho reaffirmed their purchase rating on portions of Unity Biotechnology (NASDAQ: UBX) in an exploration note discharged on Monday, November eighteenth, AnalystRatings.com reports. They at present have a $33.00 value focus on the stock.

A few different values look into examiners have ...

Short Interest by Unity Biotechnology Inc (NASDAQ:UBX)

In November, Unity Biotechnology Inc. experienced a significant rise in short interest.

As of November 15th, a total of 4,910,000 shares had a short interest, an increase of 5.8 percent from the total of 4,640,000 shares on October 31st. At present, 23.0 percent of the stock's share...

Earnings of -$0.54 Per Share Predicted to be released by Unity Biotechnology Inc.

According to Zacks Investment Research, Wall Street brokerages have predicted earnings of $0.54 per share to be released by Unity Biotechnology Inc. for this year’s present quarter. For the same quarter in 2018, the company released earnings per share of $0.48. This implies negative 12.5% y...